以電泳膠體分離及質譜儀鑑定紅斑性狼瘡(活躍期)血漿中表現差異的蛋白質

以作者查詢圖書館館藏

、以作者查詢臺灣博碩士

、以作者查詢全國書目

、勘誤回報

、線上人數：86

、訪客IP：18.188.157.9

姓名

李怡萱(Yi-Syuan Li) 查詢紙本館藏

畢業系所

系統生物與生物資訊研究所

論文名稱

以電泳膠體分離及質譜儀鑑定紅斑性狼瘡(活躍期)血漿中表現差異的蛋白質
(Identification of proteins with different expression in plasma from active systemic lupus erythematosus by gel electrophoresis and mass spectrometry)

相關論文

★ Pseudomonas putida TX2中辛基苯酚聚氧乙基醇類脫氫酶之初步純化與特性研究	★ Acinetobacter sp. OP5 與 Pseudomonas sp. TX1 參與辛基酚分解之基因群與OP5菌株之烷基鄰苯二酚2, 3加氧酵素
★ 陰離子界面活性劑sodium dodecylbenzene sulfonate分解菌篩選與脫磺酸酵素研究	★ 鄰苯二酚加氧酵素的熱穩定性提昇研究
★ Triton X-100 分解菌之分離和分解酵素之特性研究	★ Triton X-100加氧酵素之純化與定性
★ Lactobacillus reuteri於酸性與膽鹽環境中之蛋白質體研究	★ 蕃茄根部受銅逆境之基因調控
★ Pseudomonas nitroreducens TX1 異化辛基苯酚聚氧乙基醇之功能性蛋白質體學：以二維電泳法分析等電點4-8之蛋白質表現	★ Pseudomonas nitroreducens TX1之具耗氧活性之麩胺酸合成酶之單離
★ 人類細胞株生產含多種亞型的干擾素-a之蛋白質體學研究	★ 辛基苯酚之分解:分解菌和生物復育之菌相研究
★ 分解辛基苯酚聚氧乙基醇之耗氧酵素（二氫硫辛醯胺脫氫酶）的純化與定性	★ AtNPR1轉殖番茄之性狀分析及抗病機制研究
★ Pseudomonas putida TX2分解辛基苯酚聚氧乙基醇及其具雌激素活性代謝物之研究	★ 以功能性蛋白質體學研究Pseudomonas nitroreducens TX1生長於辛基苯酚聚氧乙基醇之代謝與逆境反應

檔案

[Endnote RIS 格式]

[Bibtex 格式]

[相關文章]

[文章引用]

[完整記錄]

[館藏目錄]

至系統瀏覽論文 ( 永不開放)

摘要(中)

紅斑性狼瘡是一種具有多種臨床病症，由自體免疫異常所導致的自體免疫性疾病，
屬於風濕病的其中一種。紅斑性狼瘡症狀包含皮疹、發燒、關節炎、感到疲倦及腎絲球
炎及神經症狀等，紅斑性狼瘡症狀與其他疾病相似，因此容易誤診。本實驗主要目的為
尋找台灣紅斑性狼瘡與健康人體中不同的蛋白質，可提供具潛力的生物標記分子，應用
於此疾病之診斷上。國泰綜合醫院過敏免疫科提供血漿樣本，共有19 位病人 (包含18
位女性與1 位男性) 及12 位健康對照組 (包含9 位女性與3 位男性)，病人平均年齡為
32.1±11.5，健康對照組之平均年齡為41.9±12.2。利用蛋白質體學的方法，固定血漿蛋
白總量，並以1 維與2 維膠體電泳法將病患及健康對照組的蛋白質進行分離，以影像分
析將蛋白質表現量進行統計分析，病人與健康對照組的數值比較，選取具差異的蛋白質
(U-test, p<0.5)，從膠體上切下，經過蛋白質水解酵素水解後，利用兩種質譜儀 (MALDI
Q-TOF and ESI-MS/MS) 進行蛋白質體身份鑑定。此實驗中，一共找到15 個蛋白質，9
個為表現量增加的蛋白質。其中9 個蛋白質是文獻已發表和紅斑性狼瘡有關，顯示本方
法可快速全面檢視表現差異蛋白質。而6 個蛋白質為本研究首次發現與紅斑性狼瘡有關，
顯示本方法可提供其他方法無法測得之差異蛋白質。本研究提供了快速尋找新紅斑性狼
瘡具潛力的生物標記分子的方法，將來也可能可以應用於利用血漿樣品尋找其他疾病的
潛力蛋白質標記分子。

摘要(英)

Systemic lupus erythematous (SLE) exhibits an aggressive clinical phenotype with
severe complications and overall poor prognosis. Common initial and chronic complaints
include fever, joint pains, fatigue and temporary loss of cognitive abilities. These symptoms
are so similar with other disease, so it is very difficult to diagnose and treat. The goal of this
study is to identify significant different proteins between SLE patients compared to healthy
people, the significant proteins may help to diagnose SLE patients. The SLE plasma samples
which included male and 18 female patients, with average age 32.1±11.5 also diagnosed with
renal involvement. The SLE plasma samples were collected from Cathay General Hospital,
Taipei, Taiwan. The protein profile from patients was randomly compared to that from twelve
healthy controls from 3 male and 9 female with average age at 41.9±12.2. The protein
concentration in the plasma samples was quantified and the total protein was separated by
one-dimensional and two-dimensional SDS-polyacrylamide gel electrophoresis. The up- and
down-regulated proteins compared to healthy plasma (U-test, p < 0.5) were selected and cut
from the gels and digested with trypsin for enzymatic analysis of protein using mass
spectrophotometry for identification of proteomic analysis followed by the amino acid
sequencing with mass spectrometry (MALDI-TOF/TOF and ESI-MS/MS). This experiments
results a total of 15 proteins found, 9 proteins are up-regulated and 6 proteins are down
regulated. In total of 15 proteins, nine proteins are published relation with lupus and six
proteins are new.These new proteins in the SLE patients may contribute to find the new
potential lupus biomarkers determine the precise role of newly identified SLE-related proteins
pathogenesis and their function as biomarkers will require further study.

關鍵字(中)

★ 紅斑性狼瘡
★ 蛋白質體學
★ 膠體電泳

關鍵字(英)

★ systemic lupus erythematosus
★ proteomic
★ electrophoresis

論文目次

中文摘要 I
Abstract III
I: Introduction: 1
1.1 Autoimmune disease 1
1.2 Systemic lupus erythematosus 2
1.3 Diagnosis 3
1.4 Treatment 5
1.5 Prognosis 6
1.6 Biomarkers 7
1.7 SLE biomarkers 8
1.8 Research aim: 12
II: Materials and methods 14
2.1 Preparation of proteins from samples 14
2.1.1 Protein dilution 14
2.1.2 Proteins quantitation 15
2.2 One-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis (1D SDS-PAGE) 16
2.3 SDS-PAGE image analysis and statistics 17
2.4 Two-dimensional gel electrophoresis 17
2.5 2-DE gel image analysis and statistics 18
2.6 In-gel digestion 19
2.7 Mass spectrometry 19
2.7.1 MALDI-TOF 20
2.7.2 LC ESI MS/MS 20
2.8 Database searching 21
III: Result 24
3.1 The laboratory main parameters of 19 SLE patients and 12 healthy controls 24
3.2 Variation in plasma protein expression between lupus patients and healthy controls in 1D SDS-PAGE 24
3.3 Identification of the proteins in 1D SDS-PAGE by MALDI TOF/TOF mass and LC-ESI MS/MS 24
3.4 Variation in plasma protein expression between lupus patients and healthy control in 2D electrophoresis 25
3.5 Identification of the protein in 2D electrophoresis by MALDI TOF/TOF mass 27
IV: Discussion 27
V: Conclusion 32
VI: Reference 34
VII: Figure 41
41
VII: Table 104
VIII: Appendix 108

參考文獻

Aguiar, F. M. B., Z. L. C. Menescal, et al. (2012). "Protein-losing enteropathy in systemic lupus erythematosus: case report." Rev Bras Reumatol 52(6): 956-964.
Ahearn, J. M., C. C. Liu, et al. (2012). "Biomarkers for systemic lupus erythematosus." Translational Research 159(4): 326-342.
Al-Maini, M. H., J. D. Mountz, et al. (2000). "Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus." Lupus 9(2): 132-139.
Alba, P., L. Bento, et al. (2003). "Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis." Ann Rheum Dis 62(6): 556-560.
Ames, P. R., J. Alves, et al. (2000). "Fibrinogen in systemic lupus erythematosus: more than an acute phase reactant?" J Rheumatol 27(5): 1190-1195.
Asanuma, Y., A. Oeser, et al. (2003). "Premature coronary-artery atherosclerosis in systemic lupus erythematosus." New England Journal of Medicine 349(25): 2407-2415.
Bambauer, R. and A. Arnold (1999). "Plasmapheresis with a substitution solution of human serum protein (5%) versus plasmapheresis with a substitution solution of human albumin (5%) in patients suffering from autoimmune diseases." Artificial Organs 23(12): 1079-1087.
Bauer, J. W., E. C. Baechler, et al. (2006). "Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus." PLoS Med 3(12): 2274-2284.
Biesen, R., C. Demir, et al. (2008). "Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus." Arthritis Rheum 58(4): 1136-1145.
Bigler, C., M. Lopez-Trascasa, et al. (2008). "Antinucleosome antibodies as a marker of active proliferative lupus nephritis." American Journal of Kidney Diseases 51(4): 624-629.
Brunner, H. I., M. R. Bennett, et al. (2012). "Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis." Arthritis Rheum 64(8): 2687-2697.
Carrillo, S. T., E. Gantz, et al. (2012). "Anesthetic considerations for the patient with systemic lupus erythematosus." Middle East J Anesthesiol 21(4): 483-492.
Cazzolla, N., L. Saso, et al. (1999). "Development of an enzyme-linked immunosorbent assay, using a monoclonal antibody against alpha(2)-macroglobulin, for the diagnosis of systemic lupus erythematosus." Clin Biochem 32(4): 249-255.
Chehimi, J., M. Elder, et al. (2001). "Cytokine and chemokine dysregulation in hyper-IgE syndrome." Clin Immunol 100(1): 49-56.
Chousa, M., H. Ito, et al. (2008). "The measurement of serum ceruloplasmin is useful for diagnostic differentiation of immune thrombocytopenic purpura." Clin Chim Acta 389(1-2): 132-138.
Chung, C. P., A. G. Long, et al. (2009). "Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis." Lupus 18(9): 799-806.
Cohen, P. L., R. G. Rapoport, et al. (1985). "Hidden autoantibodies against common serum proteins in murine systemic lupus erythematosus. Detection by in vitro plaque-forming cell assay." Journal of Experimental Medicine 161(6): 1587-1592.
Csipo, I., M. Kavai, et al. (1997). "Serum complement activation of SLE patients during plasmapheresis." Autoimmunity 25(3): 139-146.
Cunningham, J., M. Leffell, et al. (1995). "Elevated Plasma Ceruloplasmin in Insulin-Dependent Diabetes-Mellitus - Evidence for Increased Oxidative Stress as a Variable Complication." Metabolism-Clinical and Experimental 44(8): 996-999.
Daha, M. R., H. M. Hazevoet, et al. (1983). "Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus." Clin Exp Immunol 54(1): 248-252.
Das, L. and H. I. Brunner (2009). "Biomarkers for renal disease in childhood." Curr Rheumatol Rep 11(3): 218-225.
Decker, E. D., Y. Zhang, et al. (2003). "Proteomic analysis of differential protein expression induced by ultraviolet light radiation in HeLa cells." Proteomics 3(10): 2019-2027.
Denko, C. W. and P. Gabriel (1979). "Serum proteins--transferrin, ceruloplasmin, albumin, alpha 1-acid glycoprotein, alpha 1-antitrypsin--in rheumatic disorders." J Rheumatol 6(6): 664-672.
Dhir, V. (2012). "Biomarkers in systemic lupus erythematosus: Do they make the mark?" Indian Journal of Rheumatology 7(1): 13-20.
E. D. FLORY, B. J. C., AND K. D. MUIRDEN (1982). "Deposits of a2M in the rheumatoid synovial membrane." Annals of the Rheumatic Diseases 41: 520-526.
Einav, S., O. O. Pozdnyakova, et al. (2002). "Complement C4 is protective for lupus disease independent of C3." Journal of Immunology 168(3): 1036-1041.
Ekdahl, K. N., L. Ronnblom, et al. (1997). "Increased phosphate content in complement component C3, fibrinogen, vitronectin, and other plasma proteins in systemic lupus erythematosus: covariation with platelet activation and possible association with thrombosis." Arthritis Rheum 40(12): 2178-2186.
Ellederova, Z., P. Halada, et al. (2004). "Protein patterns of pig oocytes during in vitro maturation." Biol Reprod 71(5): 1533-1539.
Ferreira, A. C., F. Carvalho, et al. (2012). "Familial amyloidotic polineuropathy and systemic lupus." Lupus 21(13): 1455-1458.
Gallagher, S. R. (2006). "SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)." Curr. Protoc. Mol. Biol. 75(10): 7.3.1.
Garcia-Ramirez, M., F. Canals, et al. (2007). "Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy." Diabetologia 50(6): 1294-1303.
Gharbi, M., M. Deberg, et al. (2011). "Application for proteomic techniques in studying osteoarthritis: a review." Front Physiol 2: 90.
Gil-Agusti, M. T., N. Campostrini, et al. (2005). "Two-dimensional mapping as a tool for classification of green coffee bean species." Proteomics 5(3): 710-718.
Glavinskaia, T. A. and N. A. Dobrotina (1973). "[Ceruloplasmin and haptoglobin in evaluating the activity and systemic nature of lupus erythematosus]." Vopr Revm 13(1): 82-86.
Glavinskaia, T. A., A. V. Rezaikina, et al. (1989). "[HLA and ceruloplasmin phenotypes in lupus erythematosus and circumscribed scleroderma]." Vestn Dermatol Venerol(6): 9-13.
Hatanaka, Y., T. Okano, et al. (2003). "Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene." Internal Medicine 42(7): 599-604.
Hrycek, A., G. Pochopien-Kenig, et al. (2007). "Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide." Autoimmunity 40(3): 217-222.
Huang, C. M., C. H. Tsai, et al. (2004). "Epidermal growth factor receptor (EGFR) gene Bsr-I polymorphism is associated with systemic lupus erythematosus." Lupus 13(10): 773-776.
Huang, S. T., G. Y. Chen, et al. (2008). "Effect of disease activity and position on autonomic nervous modulation in patients with systemic lupus erythematosus." Clin Rheumatol 27(3): 295-300.
Ilan, Y., M. Hillman, et al. (1991). "Undetectable caeruloplasmin values in a patient with autoimmune chronic active hepatitis." Gut 32(5): 549-550.
Kao, A. H., J. S. Navratil, et al. (2010). "Erythrocyte C3d and C4d for Monitoring Disease Activity in Systemic Lupus Erythematosus." Arthritis Rheum 62(3): 837-844.
Kemeny, L., M. Mehravaran, et al. (2002). "Elevated serum caeruloplasmin level in a patient with adult Still’s disease." British Journal of Dermatology 146(3): 508-510.
Kobayashi, T. and S. Eguchi (2012). "The Epidermal Growth Factor Receptor A Missing Link Between Endoplasmic Reticulum Stress and Diabetic Complications?" Hypertension 60(1): 20-21.
Koski, H., Y. T. Konttinen, et al. (1997). "Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in labial salivary glands in Sjogren’s syndrome." Journal of Rheumatology 24(10): 1930-1935.
Kotajima, L., S. Aotsuka, et al. (1997). "Clinical significance of serum thrombomodulin levels in patients with systemic rheumatic diseases." Clin Exp Rheumatol 15(1): 59-65.
Kurien, B. T., Y. Dorri, et al. (2012). "Induction of anti-Ro60/anti-La by immunisation with spectrin and induction of anti-spectrin by immunisation with Ro60 and 4-hydroxy-2-nonenal-modified Ro60 immunisation." Clin Exp Rheumatol 30(6): 886-893.
Kurien, B. T. and R. H. Scofield (2006). "Lipid peroxidation in systemic lupus erythematosus." Indian J Exp Biol 44(5): 349-356.
Lacki, J. K., T. Schochat, et al. (1995). "IgA-alpha-1-antitrypsin complex in systemic lupus erythematosus: preliminary report." Lupus 4(3): 221-224.
Li, T. W., B. R. Zheng, et al. (2010). "Screening disease-associated proteins from sera of patients with rheumatoid arthritis: a comparative proteomic study." Chin Med J (Engl) 123(5): 537-543.
Liphaus, B. L., A. A. Jesus, et al. (2012). "Increased IgE serum levels are unrelated to allergic and parasitic diseases in patients with juvenile systemic lupus erythematosus." Clinics (Sao Paulo) 67(11): 1275-1280.
Liu, C. C., S. Manzi, et al. (2005). "Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus." Arthritis Rheum 52(10): 3087-3099.
Lopez-Avila, V., O. Sharpe, et al. (2006). "Determination of ceruloplasmin in human serum by SEC-ICPMS." Anal Bioanal Chem 386(1): 180-187.
Losada, A., T. Yokochi, et al. (2005). "Functional contribution of Pds5 to cohesin-mediated cohesion in human cells and Xenopus egg extracts." Journal of Cell Science 118(10): 2133-2141.
Mackiewicz, A., M. A. Khan, et al. (1989). "Serum IgA, acute phase proteins, and glycosylation of alpha 1-acid glycoprotein in ankylosing spondylitis." Ann Rheum Dis 48(2): 99-103.
Marrack, P., J. Kappler, et al. (2001). "Autoimmune disease: why and where it occurs." Nat Med 7(8): 899-905.
Martinez-Cordero, E., B. E. R. Garcia, et al. (1997). "Anticardiolipin antibodies in serum and cerebrospinal fluid from patients with systemic lupus erythematosus." Journal of Investigational Allergology & Clinical Immunology 7(6): 596-601.
Misra, U. K., M. GonzalezGronow, et al. (1997). "Up-regulation of the alpha(2)-macroglobulin signaling receptor on rheumatoid synovial fibroblasts." Journal of Biological Chemistry 272(1): 497-502.
Morgan, P. E., A. D. Sturgess, et al. (2009). "Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients." Free Radic Res 43(2): 117-127.
Nielsen, S., A. Schmitz, et al. (1999). "Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin." Diabetologia 42(1): 60-67.
Nowak, M., T. Wielkoszynski, et al. (2010). "Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy." Clin Exp Med 10(3): 185-192.
Okamoto, N., S. Wada, et al. (1996). "Hereditary ceruloplasmin deficiency with hemosiderosis." Human Genetics 97(6): 755-758.
OkawaTakatsuji, M., S. Aotsuka, et al. (1996). "Clinical significance of the serum lipoprotein(a) level in patients with systemic lupus erythematosus: Its elevation during disease flare." Clin Exp Rheumatol 14(5): 531-536.
Parra, S., G. Vives, et al. (2012). "Complement system and small HDL particles are associated with subclinical atherosclerosis in SLE patients." Atherosclerosis 225(1): 224-230.
Pavon, E. J., S. Garcia-Rodriguez, et al. (2012). "Increased expression and phosphorylation of the two S100A9 isoforms in mononuclear cells from patients with systemic lupus erythematosus: a proteomic signature for circulating low-density granulocytes." J Proteomics 75(6): 1778-1791.
Qamar, A. A., S. K. Burke, et al. (2012). "The ability of serum from alpha 1-antitrypsin-deficient patients to inhibit PRT-201, a recombinant human type I pancreatic elastase." Biotechnol Appl Biochem 59(1): 22-28.
R., K. G. a. L. T. (1968). "alphe-Isopropylmalate Synthase from Salmonella typhimurium." The journal of biological chemistry 244(8): 2218-2225.
Rantapaa Dahlqvist, S., G. Beckman, et al. (1988). "Serum protein markers in systemic lupus erythematosus." Hum Hered 38(1): 44-47.
Ravaud, A., H. de Clermont, et al. (2007). "Epithelial growth factor receptor (EGFR) pathway and renal cell carcinoma." Targeted Oncology 2(2): 99-105.
Reid, H. L. and K. De Ceulaer (1999). "Abnormal plasma and serum viscosity in systemic lupus erythematosus (SLE): A Jamaican study." Clinical Hemorheology and Microcirculation 20(3): 175-180.
Robak, T. and E. Robak (2012). "Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders." Expert Opinion on Investigational Drugs 21(7): 921-947.
Rovin, B. H., H. J. Song, et al. (2005). "Urine chemokines as biomarkers of human systemic lupus erythematosus activity." Journal of the American Society of Nephrology 16(2): 467-473.
Rubinstein, T., M. Pitashny, et al. (2010). "Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis." Rheumatology 49(5): 960-971.
Saso, L., B. Silvestrini, et al. (1993). "Abnormal Glycosylation of Alpha(2)-Macroglobulin, a Non-Acute-Phase Protein, in Patients with Autoimmune-Diseases." Inflammation 17(4): 465-479.
Saso, L., B. Silvestrini, et al. (1993). "Changes of immunoreactivity in alpha 1-antitrypsin in patients with autoimmune diseases." Inflammation 17(3): 383-400.
Schweer, D., M. Jacobsen, et al. (2001). "No association of three polymorphisms in the alpha-2-macroglobulin and lipoprotein related receptor genes with multiple sclerosis." J Neuroimmunol 118(2): 300-303.
Scott, L. J., E. L. Evans, et al. (1998). "Comparison of IgA-alpha1-antitrypsin levels in rheumatoid arthritis and seronegative oligoarthritis: complex formation is not associated with inflammation per se." Br J Rheumatol 37(4): 398-404.
Shetty, V., J. Hafner, et al. (2012). "Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics." Clin Proteomics 9(1): 10.
Silvestrini, B., A. Guglielmotti, et al. (1990). "Development of an enzyme-linked immunosorbent assay with a monoclonal antibody prepared against alpha 1-antitrypsin for diagnostic screening of inflammatory disorders." Clin Chem 36(2): 277-282.
Slrnalley, D. M., N. E. Sheman, et al. (2008). "Isolation and identification of potential urinary microparticle biomarkers of bladder cancer." J Proteome Res 7(5): 2088-2096.
Somparn, P., N. Hirankarn, et al. (2012). "Urinary proteomics revealed prostaglandin H(2)D-isomerase, not Zn-alpha2-glycoprotein, as a biomarker for active lupus nephritis." J Proteomics 75(11): 3240-3247.
Sule, S. D., J. J. Fadrowski, et al. (2009). "Persistent low albumin and temporary vascular access in pediatric patients with SLE on hemodialysis." Pediatric Nephrology 24(10): 1981-1987.
Suzuki, M., K. Wiers, et al. (2009). "Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis." Pediatr Res 65(5): 530-536.
Takada, Y., Y. Ono, et al. (2010). "A T cell-binding fragment of fibrinogen can prevent autoimmunity." J Autoimmun 34(4): 453-459.
Taysi, S., M. Gul, et al. (2002). "Serum oxidant/antioxidant status of patients with systemic lupus erythematosus." Clin Chem Lab Med 40(7): 684-688.
Taysi, S., I. Kocer, et al. (2002). "Serum oxidant/antioxidant status in patients with Behcet’s disease." Ann Clin Lab Sci 32(4): 377-382.
Torrente-Segarra, V., M. P. Lisbona, et al. (2012). "Hand and wrist arthralgia in systemic lupus erythematosus is associated to ultrasonographic abnormalities." Joint Bone Spine.
Trachtman, H., E. Christen, et al. (2006). "Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury." Pediatric Nephrology 21(7): 989-994.
Vaya, A., J. Calvo, et al. (2012). "Rheological alterations and thrombotic events in patients with systemic lupus erythematosus." Clin Hemorheol Microcirc 51(1): 51-58.
Wakefield, D., J. Easter, et al. (1985). "Alpha 1 antitrypsin serum levels and phenotypes in patients with retinal vasculitis." Br J Ophthalmol 69(7): 497-499.
Walport, M. J. (2002). "Complement and systemic lupus erythematosus." Arthritis Res 4 Suppl 3: S279-293.
Warrier, R. P., S. Sahney, et al. (1984). "Hemoglobin sickle cell disease and systemic lupus erythematosus." J Natl Med Assoc 76(10): 1030-1031.
Yaddanapudi, K., M. Hornig, et al. (2010). "Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection." Mol Psychiatry 15(7): 712-726.
Yamaguchi, H., J. Takagi, et al. (2008). "Milk fat globule EGF factor 8 in the serum of human patients of systemic lupus erythematosus." J Leukoc Biol 83(5): 1300-1307.
Yang, D. H., D. M. Chang, et al. (2009). "Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus." Rheumatology 48(9): 1083-1087.
Yilmaz, A., R. A. Sari, et al. (2005). "Trace elements and some extracellular antioxidant proteins levels in serum of patients with systemic lupus erythematosus." Clin Rheumatol 24(4): 331-335.
Yip, J., E. Aghdassi, et al. (2010). "Serum Albumin as a Marker for Disease Activity in Patients with Systemic Lupus Erythematosus." Journal of Rheumatology 37(8): 1667-1672.
Zhang, X. H., Y. H. Yan, et al. (1989). "Changes of neutrophil elastase and alpha 1-antitrypsin in systemic lupus erythematosus." Proc Chin Acad Med Sci Peking Union Med Coll 4(1): 26-29.
Zhang, Y., Y. Li, et al. (2010). "Comparative analysis of the human urinary proteome by 1D SDS-PAGE and chip-HPLC-MS/MS identification of the AACT putative urinary biomarker." J Chromatogr B Analyt Technol Biomed Life Sci 878(32): 3395-3401.

指導教授

黃雪莉(Shir-Ly Huang)

審核日期

2013-8-28

推文